Brugada syndrome is an unprecedented inherited arrhythmia syndrome which may lead to an increased risk of unexpected cardiac loss of life, in spite of a structurally regular heart. Symptoms include palpitations, syncope, nocturnal agonal respiration, ventricular fibrillation. Diagnosis is primarily based totally on a specific electrocardiogram pattern, determined both spontaneously and in the course of a sodium channel blocker test. Some pathogenic genes are identified as the causative agents of the disease. Among those SCN5A is the most prevalent one among affected sufferers Key stratification stays a venture, in spite of latest insights from big population cohorts. Implantable cardiac defibrillators are the primary remedy in management of Brugada syndrome which is related to excessive complications in the population. This review explains the genetic basis, diagnosis, risk stratification, management and steps for enhancing good health care team outcomes.
Share this article
Select your language of interest to view the total content in your interested language